Barbara D. Wamil

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial

Ian Smith, Denise A. Yardley, Howard A. Burris et al. · Journal of Clinical Oncology · 2017 · 120 citations

Breast Oncology, Gynecology, Pharmacotherapy +16

Teriflunomide added to interferon-β in relapsing multiple sclerosis

M. S. Freedman, Jerry S. Wolinsky, Barbara D. Wamil et al. · Neurology · 2012 · 78 citations

CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury

Artur W. Wamil, Barbara D. Wamil, Carl G. Hellerqvist · Proceedings of the National Academy of Sciences · 1998 · 57 citations

Phase I study of the antineovascularization drug CM101.

Russell F. DeVore, Carl G. Hellerqvist, GAIL WAKEFIELD et al. · PubMed · 1997 · 41 citations

Bacterial Polysaccharide, Immunology, Pathology +18

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

Barbara D. Wamil, Gary B. Thurman, Håkan Sundell et al. · Journal of Cancer Research and Clinical Oncology · 1997 · 29 citations · Full text

Soluble E-selectin, Tumor-inhibiting Anti-neovascularization Agent, Medicine +9